United States

People: DURECT Corp (DRRX.O)

DRRX.O on Consolidated Issue listed on NASDAQ Global Market

21 Jul 2017
Change (% chg)

$0.02 (+1.08%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Brown, James 

Dr. James E. Brown, DVM., is President, Chief Executive Officer and Director of DURECT Corporation. He co-founded DURECT in February 1998 and has served as our President, Chief Executive Officer and a Director since June 1998. He previously worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development from June 1995 to June 1998. Prior to that, Dr. Brown held various positions at Syntex Corporation, a pharmaceutical company, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April 1992 to May 1995, and held a number of positions including Program Director for Syntex Research and Development from October 1985 to March 1992. Dr. Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology. Dr. Brown’s scientific expertise and pharmaceutical industry experience as well as the valuable perspective as the Company’s Chief Executive Officer and co-founder into the management, strategies and operations of the Company are among the special qualifications that he brings to his service as a Director of the Company.

Basic Compensation

Total Annual Compensation, USD 470,385
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 485,341
Fiscal Year Total, USD 955,726

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --